Element Pointe Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$337K Buy
281
+62
+28% +$63.3K 0.05% 73
2026
Q1
$202K Hold
219
0.04% 83
2025
Q4
$235K Buy
+219
New +$209K 0.05% 74

Other funds holding LLY

Element Pointe Advisors's LLY Position: Q2 2026 in Review

Element Pointe Advisors increased its Eli Lilly (LLY) stake by 28% in Q2 2026, buying an estimated $63.3K and bringing the position to 281 shares worth $337K. The position accounts for 0.05% of the portfolio, ranked #73.

Element Pointe Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Element Pointe Advisors held 281 shares of Eli Lilly worth $337K as of Q2 2026.
  • Element Pointe Advisors bought 62 Eli Lilly shares in Q2 2026, an estimated $63.3K.
  • Eli Lilly made up 0.05% of Element Pointe Advisors's portfolio in Q2 2026, its #73 holding.
  • Element Pointe Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Element Pointe Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.